ArticleFrontiers in oncology2022

Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients.

Andrea Boutros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.